- Home
- JFR vs IRMD Comparison
JFR vs IRMD Comparison
Compare JFR & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFR | IRMD |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | JFR | IRMD |
|---|---|---|
| Price | $7.74 | $100.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $72.00 |
| AVG Volume (30 Days) | ★ 621.7K | 71.2K |
| Earning Date | 01-01-0001 | 02-10-2026 |
| Dividend Yield | ★ 11.31% | 0.80% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $10.85 |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | ★ N/A | $57.03 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $7.61 | $47.48 |
| 52 Week High | $8.82 | $107.90 |
Technical Indicators
Market Signals| Indicator | JFR | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 53.07 |
| Support Level | $7.76 | $98.90 |
| Resistance Level | $7.89 | $107.90 |
| Average True Range (ATR) | 0.06 | 3.63 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 6.58 | 47.56 |
Price Performance
Historical ComparisonAbout JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.